Starling Brands sells Kase Farma subsidiary to HTC Extraction Systems

1 minute read
29 January 2020

On Jan. 29, 2020, HTC Extraction Systems (TSXV: HTC) (OTCQB: HTPRF) announced that it had closed its previously announced purchase of all the issued and outstanding shares of Kase Farma Inc. from Starling Brands, Inc.

As part of the transaction, Kase Farma has entered into an intellectual property licensing agreement with Starling Brands that allows for a technology transfer, whereby intellectual property and technology licensed under the agreement will be utilized and deployed in HTC's Canadian facility.

Kase Farma, now a wholly owned subsidiary of HTC, is authorized to operate in the areas of hemp cultivation, extraction, refining and formulation in the State of California.

Gowling WLG was Canadian counsel to Starling Brands with respect to this transaction with a team that included Peter Simeon and Warren Cass.

NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.